B细胞-话题@MedSci

#B细胞#

314篇内容 | 6292人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273266, encodeId=a22f12e3266e2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：在分子上，前体B细胞表型的IG-MYC阳性肿瘤与伯基特淋巴瘤明显不同, objectType=article, longId=150550, objectId=29ed15055028, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29ed15055028, replyNumber=0, likeNumber=90, createdTime=2018-10-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29ed15055028, moduleTitle=Blood：在分子上，前体B细胞表型的IG-MYC阳性肿瘤与伯基特淋巴瘤明显不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29ed15055028)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273265, encodeId=ad5e12e3265b3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：可通过石蜡切片鉴别原发性纵膈大B细胞淋巴瘤的分子分类方法, objectType=article, longId=149771, objectId=d9d1149e71c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9d1149e71c5, replyNumber=0, likeNumber=79, createdTime=2018-09-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9d1149e71c5, moduleTitle=Blood：可通过石蜡切片鉴别原发性纵膈大B细胞淋巴瘤的分子分类方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9d1149e71c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273264, encodeId=5f1712e32647a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：将嵌合抗原受体引物T细胞不能完全解决前体B细胞ALL诱导的T细胞功能障碍, objectType=article, longId=148878, objectId=e5361488e821, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5361488e821, replyNumber=0, likeNumber=94, createdTime=2018-09-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5361488e821, moduleTitle=Blood：将嵌合抗原受体引物T细胞不能完全解决前体B细胞ALL诱导的T细胞功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5361488e821)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273263, encodeId=131812e326311, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, objectType=article, longId=148786, objectId=bee6148e86b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bee6148e86b0, replyNumber=0, likeNumber=112, createdTime=2018-09-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bee6148e86b0, moduleTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee6148e86b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273262, encodeId=392512e32620b, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Cell：回答过去无法回答的问题：B细胞对MS的特殊作用, objectType=article, longId=148342, objectId=c198148342f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c198148342f4, replyNumber=0, likeNumber=60, createdTime=2018-09-08, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c198148342f4, moduleTitle=Cell：回答过去无法回答的问题：B细胞对MS的特殊作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c198148342f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273261, encodeId=278512e326128, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=CLIN CANCER RES：克服侵袭性B细胞淋巴瘤Venetoclax耐药策略, objectType=article, longId=147811, objectId=c09f14e81109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c09f14e81109, replyNumber=0, likeNumber=68, createdTime=2018-09-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c09f14e81109, moduleTitle=CLIN CANCER RES：克服侵袭性B细胞淋巴瘤Venetoclax耐药策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c09f14e81109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273260, encodeId=d93712e326088, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=JCO：循环肿瘤DNA作为弥漫大B细胞淋巴瘤早期结局预测指标, objectType=article, longId=147188, objectId=34ac14e18870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ac14e18870, replyNumber=0, likeNumber=101, createdTime=2018-08-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ac14e18870, moduleTitle=JCO：循环肿瘤DNA作为弥漫大B细胞淋巴瘤早期结局预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34ac14e18870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273259, encodeId=acad12e3259b2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效, objectType=article, longId=145755, objectId=8b22145e5508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b22145e5508, replyNumber=0, likeNumber=72, createdTime=2018-08-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b22145e5508, moduleTitle=Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b22145e5508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273258, encodeId=ef2f12e32584c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, objectType=article, longId=145217, objectId=49aa14521efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49aa14521efb, replyNumber=0, likeNumber=97, createdTime=2018-07-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49aa14521efb, moduleTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49aa14521efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273257, encodeId=4f3112e325798, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：肿瘤特异性T细胞不能根除淋巴瘤起始B细胞！, objectType=article, longId=144636, objectId=797e14463657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=797e14463657, replyNumber=0, likeNumber=68, createdTime=2018-07-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=797e14463657, moduleTitle=Blood：肿瘤特异性T细胞不能根除淋巴瘤起始B细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=797e14463657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273256, encodeId=365412e325660, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, objectType=article, longId=144543, objectId=35051445433e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35051445433e, replyNumber=0, likeNumber=122, createdTime=2018-07-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35051445433e, moduleTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35051445433e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273255, encodeId=0c2012e325545, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, objectType=article, longId=144538, objectId=cc1d14453882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d14453882, replyNumber=0, likeNumber=87, createdTime=2018-07-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d14453882, moduleTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d14453882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273254, encodeId=b9ed12e3254d5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读, objectType=article, longId=142014, objectId=8f2314201407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f2314201407, replyNumber=0, likeNumber=46, createdTime=2018-07-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f2314201407, moduleTitle=《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f2314201407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273253, encodeId=d0ae12e325397, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, objectType=article, longId=141010, objectId=cb7914101089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7914101089, replyNumber=0, likeNumber=32, createdTime=2018-06-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7914101089, moduleTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb7914101089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273252, encodeId=4d8912e32528c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Cell Res：用新型蛋白质靶向降解技术克服Ibrutinib耐药的B细胞恶性肿瘤, objectType=article, longId=140766, objectId=ed6f140e66a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed6f140e66a3, replyNumber=0, likeNumber=74, createdTime=2018-06-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed6f140e66a3, moduleTitle=Cell Res：用新型蛋白质靶向降解技术克服Ibrutinib耐药的B细胞恶性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed6f140e66a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273251, encodeId=19f412e3251ee, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V4）, objectType=article, longId=138795, objectId=e0e8138e95cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0e8138e95cb, replyNumber=0, likeNumber=32, createdTime=2018-05-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0e8138e95cb, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0e8138e95cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273250, encodeId=c9fa12e3250f9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J Clin Oncol：奥秘皆在细微处：诊断治疗间期与新诊断弥漫大B细胞淋巴瘤预后相关, objectType=article, longId=137495, objectId=28c313e4959f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28c313e4959f, replyNumber=0, likeNumber=97, createdTime=2018-05-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28c313e4959f, moduleTitle=J Clin Oncol：奥秘皆在细微处：诊断治疗间期与新诊断弥漫大B细胞淋巴瘤预后相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28c313e4959f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273249, encodeId=0e9f12e324964, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物, objectType=article, longId=137448, objectId=21c913e448d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c913e448d2, replyNumber=0, likeNumber=68, createdTime=2018-05-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c913e448d2, moduleTitle=Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21c913e448d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273248, encodeId=451d12e324823, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：代谢异质性和总肿瘤病灶糖酵解均可作为原发纵膈B细胞淋巴瘤（PMBCL）预后预测标志物, objectType=article, longId=137142, objectId=131c13e1420c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=131c13e1420c, replyNumber=0, likeNumber=72, createdTime=2018-05-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=131c13e1420c, moduleTitle=Blood：代谢异质性和总肿瘤病灶糖酵解均可作为原发纵膈B细胞淋巴瘤（PMBCL）预后预测标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=131c13e1420c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273247, encodeId=909a12e324707, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗, objectType=article, longId=137081, objectId=3c9113e08130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c9113e08130, replyNumber=0, likeNumber=74, createdTime=2018-05-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c9113e08130, moduleTitle=【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c9113e08130)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：在分子上，前体B细胞表型的IG-MYC阳性肿瘤与伯基特淋巴瘤明显不同

2018-10-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：可通过石蜡切片鉴别原发性纵膈大B细胞淋巴瘤的分子分类方法

2018-09-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：将嵌合抗原受体引物T细胞不能完全解决前体B细胞ALL诱导的T细胞功能障碍

2018-09-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号

2018-09-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Cell：回答过去无法回答的问题：B细胞对MS的特殊作用

2018-09-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

CLIN CANCER RES：克服侵袭性B细胞淋巴瘤Venetoclax耐药策略

2018-09-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

JCO：循环肿瘤DNA作为弥漫大B细胞淋巴瘤早期结局预测指标

2018-08-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效

2018-08-05

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变

2018-07-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：肿瘤特异性T细胞不能根除淋巴瘤起始B细胞！

2018-07-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH

2018-07-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？

2018-07-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读

2018-07-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率

2018-06-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Cell Res：用新型蛋白质靶向降解技术克服Ibrutinib耐药的B细胞恶性肿瘤

2018-06-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2018.V4）

2018-05-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

J Clin Oncol：奥秘皆在细微处：诊断治疗间期与新诊断弥漫大B细胞淋巴瘤预后相关

2018-05-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物

2018-05-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：代谢异质性和总肿瘤病灶糖酵解均可作为原发纵膈B细胞淋巴瘤（PMBCL）预后预测标志物

2018-05-05

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗

2018-05-04

科室
- - 订阅+
  - 更多科室
工具
服务